Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nabilone for uremic pruritus in dialysis patients
NCT05180968Phase 3Completed
- Sponsor
- University of Manitoba
- Start
- Aug 2022
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nabilone in uremic pruritus, sponsored by University of Manitoba. Started Aug 2022; status: completed.
02
Drugs
nabilone
03
Conditions
uremic pruritus
Beyond the preview
Go deeper on NCT05180968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05180968.